Privigen Global Market Report 2025

Privigen Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Formulation (Liquid (10% solution), Lyophilized), By Indication (Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immune Thrombocytopenic Purpura (ITP), Guillain-Barré Syndrome, Other Autoimmune Disorders), By End Users (Hospitals, Clinics, Homecare settings)

Name: Privigen Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Privigen Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

What Is Covered Under Privigen Market?

Privigen is an intravenous immunoglobulin (IVIg) treatment made from human plasma. It is primarily used to manage conditions related to weakened immune systems, such as primary immunodeficiency (PI), chronic inflammatory demyelinating polyneuropathy (CIDP), and idiopathic thrombocytopenic purpura (ITP). Privigen helps boost immunity by providing antibodies that support the body in fighting infections or regulating immune responses.

The main formulation types of privigen are liquid (10% solution) and lyophilized. Privigen liquid (10% solution) is a sterile intravenous immunoglobulin (IVIg) preparation used to treat immunodeficiency disorders and autoimmune conditions by providing essential antibodies. The indications are primary immunodeficiency (PI), chronic inflammatory demyelinating polyneuropathy (CIDP), immune thrombocytopenic purpura (ITP), Guillain-Barré Syndrome, and others and it is used by various end users such as hospitals, clinics, and home care settings.

What Is The Privigen Market Size 2025 And Growth Rate?

The privigen market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to improving healthcare access, growing investments, a rise in research and development, rising cases of rare diseases, and the adoption of homecare treatments.

What Is The Privigen Market Growth Forecast?

The privigen market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to improving formulations, globalization of the pharmaceutical supply chain, growth in outpatient care facilities, growth in medical tourism, and support for patient advocacy groups. Major trends in the forecast period include advancements in diagnostic capabilities, innovation in immunoglobulin therapy, advancements in drug delivery systems, advances in biotechnology, and innovations in infusion techniques.

Privigen Market Size and growth rate 2025 to 2029: Graph

How Is The Privigen Market Segmented?

The privigen market covered in this report is segmented –

1) By Formulation: Liquid (10% solution); Lyophilized

2) By Indication: Primary Immunodeficiency (PI); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Immune Thrombocytopenic Purpura (ITP); Guillain-Barré Syndrome; Other Autoimmune Disorders

3) By End Users: Hospitals; Clinics; Homecare settings

Book your 30 minutes free consultation with our research experts

What Is Driving The Privigen Market? Rising Immunodeficiency Drives Market

The increase in the prevalence of immunodeficiency disorders is expected to propel the privigen market going forward. Immunodeficiency disorders are conditions that impair the immune system's ability to defend the body against infections and diseases. The prevalence of immunodeficiency disorders is rising due to factors such as increasing awareness and improved diagnostic capabilities, longer survival rates of individuals with primary immunodeficiencies, growing use of immunosuppressive therapies, and higher rates of chronic diseases. Privigen, an intravenous immunoglobulin (IVIG), is used to treat immunodeficiency disorders by boosting antibody levels, helping patients fight infections and maintain immune system function effectively. For instance, in May 2023, according to the University of Oxford, the 19 most common autoimmune diseases affected 3-9% of the population of the United Kingdom in 2022, which reached 10% of the population in 2023. Therefore, the rise in the prevalence of immunodeficiency disorders drives the privigen market.

What Is Driving The Privigen Market? Government Initiatives Boost Market

The rise in favorable government initiatives is expected to propel the privigen market going forward. Government initiatives in healthcare are programs, policies, or actions implemented by governments to improve public health, enhance access to medical services, and promote the well-being of their populations. The favorable government initiatives are rising due to factors such as increasing demand for affordable and accessible medical services, the need to address aging populations and chronic diseases, and advancements in medical technology. Government initiatives supporting immunodeficiency treatments help improve access to therapies such as privigen, ensuring affordable and timely care for patients through funding and healthcare programs. For instance, in February 2023, according to the National Institute for Health and Care Research, a UK-based funding agency, the funding announced for the NIHR BioResource for the research using genetic information to find new tests and treatments for rare diseases, including immunodeficiencies and hemophilia, in 2022 was $50.89 million, which in 2023 reached $1005.17 million. Therefore, the rise in favorable government initiatives drives the privigen market.

What Is Driving The Privigen Market? Rising Healthcare Expenditure Fuel Market

The rise in healthcare expenditure is expected to propel the privigen market going forward. Healthcare expenditure refers to the total amount of financial resources spent on medical services, healthcare infrastructure, pharmaceuticals, and healthcare-related activities. Healthcare expenditure is rising due to factors such as higher operational costs in healthcare facilities, increasing prevalence of chronic and lifestyle-related diseases, rise in prevalence of genetic disorders, advances in medical technology, and greater access to healthcare services. Increased healthcare expenditure facilitates better access to therapies such as privigen for immunodeficiency disorders, improving treatment availability, patient outcomes, and overall healthcare infrastructure. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the increase in healthcare expenditure drives the privigen market.

Who Are The Major Players In The Global Privigen Market?

Major companies operating in the privigen market are CSL Behring AG

Regional Analysis For The Global Privigen Market

North America was the largest region in the privigen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the privigen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the privigen market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Privigen Market?

The privigen market consists of sales of privigen liquid for primary immunodeficiency, liquid for chronic immune thrombocytopenic purpura, and liquid for chronic inflammatory demyelinating polyneuropathy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Privigen Industry?

The privigen market research report is one of a series of new reports from The Business Research Company that provides privigen market statistics, including privigen industry global market size, regional shares, competitors with a privigen market share, detailed privigen market segments, market trends and opportunities, and any further data you may need to thrive in the privigen industry. This privigen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Privigen Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The privigen market covered in this report is segmented – 1) By Formulation: Liquid (10% solution); Lyophilized 2) By Indication: Primary Immunodeficiency (PI); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Immune Thrombocytopenic Purpura (ITP); Guillain-Barré Syndrome; Other Autoimmune Disorders 3) By End Users: Hospitals; Clinics; Homecare settings
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	CSL Behring AG
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Privigen Market Characteristics

3. Privigen Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Privigen Market Trends And Strategies

5. Privigen Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Privigen Growth Analysis And Strategic Analysis Framework

6.1. Global Privigen PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Privigen Market Growth Rate Analysis

6.4. Global Privigen Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Privigen Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Privigen Total Addressable Market (TAM)

7. Global Privigen Pricing Analysis & Forecasts

8. Privigen Market Segmentation

8.1. Global Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Liquid (10% solution)

Lyophilized

8.2. Global Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Primary Immunodeficiency (PI)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Immune Thrombocytopenic Purpura (ITP)

Guillain-Barré Syndrome

Other Autoimmune Disorders

8.3. Global Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Clinics

Homecare settings

9. Global Privigen Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Privigen Market Regional And Country Analysis

10.1. Global Privigen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Privigen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Privigen Market

11.1. Asia-Pacific Privigen Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Privigen Market

12.1. China Privigen Market Overview

12.2. China Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Privigen Market

13.1. India Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Privigen Market

14.1. Japan Privigen Market Overview

14.2. Japan Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Privigen Market

15.1. Australia Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Privigen Market

16.1. South Korea Privigen Market Overview

16.2. South Korea Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Privigen Market

17.1. Western Europe Privigen Market Overview

17.2. Western Europe Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Privigen Market

18.1. UK Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Privigen Market

19.1. Germany Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Privigen Market

20.1. France Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Privigen Market

21.1. Eastern Europe Privigen Market Overview

21.2. Eastern Europe Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Privigen Market

22.1. North America Privigen Market Overview

22.2. North America Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Privigen Market

23.1. USA Privigen Market Overview

23.2. USA Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Privigen Market

24.1. Canada Privigen Market Overview

24.2. Canada Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Privigen Market

25.1. South America Privigen Market Overview

25.2. South America Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Privigen Market

26.1. Middle East Privigen Market Overview

26.2. Middle East Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Privigen Market

27.1. Africa Privigen Market Overview

27.2. Africa Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Privigen Market Competitive Landscape And Company Profiles

28.1. Privigen Market Competitive Landscape

28.2. Privigen Market Company Profiles

28.2.1. CSL Behring AG Overview, Products and Services, Strategy and Financial Analysis

28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

29. Global Privigen Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Privigen Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Privigen Market

32. Recent Developments In The Privigen Market

33. Privigen Market High Potential Countries, Segments and Strategies

33.1 Privigen Market In 2029 - Countries Offering Most New Opportunities

33.2 Privigen Market In 2029 - Segments Offering Most New Opportunities

33.3 Privigen Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Privigen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Privigen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: CSL Behring AG Financial Performance

Table 60: 0 Financial Performance

Table 61: 0 Financial Performance

Table 62: 0 Financial Performance

Table 63: 0 Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Privigen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Privigen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Privigen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Privigen Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Privigen Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: CSL Behring AG Financial Performance

Figure 60: 0 Financial Performance

Figure 61: 0 Financial Performance

Figure 62: 0 Financial Performance

Figure 63: 0 Financial Performance

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Porcine Plasma Feed Market 2023 – By Type (Powder, Grain, Other Types), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications), By End User (Farmers, Farming Organizations, Feed Additive Companies, Animal Feed For Pets), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Plasma Feed Global Market Report 2025 – By Source (Porcine, Bovine, Other Sources), By Sales Channel (Online, Offline), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Therapy Global Market Report 2025 – By Type (Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)), By Application (Orthopaedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications), By End-Users (Hospitals & Clinics, Laboratories (Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Mycoplasma Testing Global Market Report 2025 – By Product (Instruments, Assay, Kits, and Reagents), By Technology (PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies), By Application (Cell line Testing, Virus Testing, End- of- Production Cell Testing), By End User (Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cold Plasma Global Market Report 2025 – By Regime (Atmospheric Cold Plasma, Low-Pressure Cold Plasma ), By Technology (Remote Treatment, Direct Treatment, Electrode Contact ), By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By End Use Sector (Automotive, Electronics & Semiconductors, Food Processing & Packaging, Medical, Aerospace, Polymers & Plastics, Other End-User Sector) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Porcine Plasma Feed Global Market Report 2025 – By Type (Powder, Grain, Other Types), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications), By End User (Farmers, Farming Organizations, Feed Additive Companies, Animal Feed For Pets) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Fractionation Global Market Report 2025 – By Product (Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors), By Application (Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology), By End User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Protein Therapeutics Global Market Report 2025 – By Product (Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products), By Route Of Administration (Intravenous, Subcutaneous), By Applications (Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Privigen market?

How will the Privigen market drivers and restraints affect the market dynamics? What forces will shape the Privigen industry going forward?

The Privigen market major growth driver - Rising Immunodeficiency Drives Market. For further insights on the Privigen market, request a sample here

What is the forecast market size or the forecast market value of the Privigen market?

The Privigen market size has grown strongly in recent years. The privigen market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to improving healthcare access, growing investments, a rise in research and development, rising cases of rare diseases, and the adoption of homecare treatments. The privigen market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to improving formulations, globalization of the pharmaceutical supply chain, growth in outpatient care facilities, growth in medical tourism, and support for patient advocacy groups. Major trends in the forecast period include advancements in diagnostic capabilities, innovation in immunoglobulin therapy, advancements in drug delivery systems, advances in biotechnology, and innovations in infusion techniques. For further insights on the Privigen market, request a sample here

How is the Privigen market segmented?

The privigen market covered in this report is segmented –
1) By Formulation: Liquid (10% solution); Lyophilized
2) By Indication: Primary Immunodeficiency (PI); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Immune Thrombocytopenic Purpura (ITP); Guillain-Barré Syndrome; Other Autoimmune Disorders
3) By End Users: Hospitals; Clinics; Homecare settings For further insights on the Privigen market, request a sample here

Which region has the largest share of the Privigen market? What are the other regions covered in the report?

Who are the major players in the Privigen market?

Major companies operating in the privigen market are CSL Behring AG . For further insights on the Privigen market, request a sample here.

What are the key trends in the Privigen market?

Major trends in the Privigen market include . For further insights on the Privigen market, request a sample here.

What are the major opportunities in the Privigen market? What are the strategies for the Privigen market?

For detailed insights on the major opportunities and strategies in the Privigen market, request a sample here.

How does the Privigen market relate to the overall economy and other similar markets?

For detailed insights on Privigen's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Privigen industry?

For detailed insights on the mergers and acquisitions in the Privigen industry, request a sample here.

What are the key dynamics influencing the Privigen market growth? SWOT analysis of the Privigen market.

For detailed insights on the key dynamics influencing the Privigen market growth and SWOT analysis of the Privigen industry, request a sample here.

Privigen Global Market Report 2025

Privigen Global Market Report 2025

What Is Covered Under Privigen Market?

What Is The Privigen Market Size 2025 And Growth Rate?

What Is The Privigen Market Growth Forecast?

How Is The Privigen Market Segmented?

What Is Driving The Privigen Market? Rising Immunodeficiency Drives Market

What Is Driving The Privigen Market? Government Initiatives Boost Market

What Is Driving The Privigen Market? Rising Healthcare Expenditure Fuel Market

Who Are The Major Players In The Global Privigen Market?

Regional Analysis For The Global Privigen Market

What Defines the Privigen Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Privigen Industry?

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions